Translational control of retroviruses

Nature Reviews Microbiology

Volumn 5, Issue 2, 2007, Pages 128-140

  Balvay, Laurent ^a,b   Lastra, Marcelo Lopez ^c   Sargueil, Bruno ^d   Darlix, Jean Luc ^a,b   Ohlmann, Théophile ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DOUBLE STRANDED DNA; GAG PROTEIN; GENOMIC RNA; INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4E; INITIATION FACTOR 4G; MESSENGER RNA PRECURSOR; POL PROTEIN; POLYADENYLIC ACID BINDING PROTEIN; PROTEIN KINASE R; PROTEIN P40; PROTEIN P43; PROTEIN P44; PROTEIN P50; PROTEINASE; PROTEINASE INHIBITOR; REV PROTEIN; RNA DIRECTED DNA POLYMERASE; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TRANSFER RNA; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

CYTOPLASM; DNA FLANKING REGION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNAL RIBOSOME ENTRY SITE; LENTIVIRINAE; MURINE LEUKEMIA VIRUS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROVIRUS; REVIEW; RNA PROCESSING; RNA STRUCTURE; RNA TRANSLATION; SIMIAN IMMUNODEFICIENCY VIRUS; SPUMA VIRUS; TRANSLATION INITIATION; TRANSLATION REGULATION; VIRION; VIRUS ASSEMBLY; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; PROTEIN BIOSYNTHESIS; RETROVIRIDAE; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 33846507162     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1599     Document Type: Review

References (148)

1. Telenitsky, A. & Goff, S. P. in Retroviruses (eds Coffin, J. M, Hughes, S. M. & Varmus, H. E) 121-160 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1997).
2. Paillart, J. C., Shehu-Xhilaga, M., Marquet, R. & Mak, J. Dimerization of retroviral genomes: An inseperable pair. Nature Rev. Mircobiol. 2, 461-472 (2004).
3. Vogt, P. K. in Retroviruses (eds Coffin, J. M., Hughes, S. M. & Varmus, H. E.) 1-25 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1997).
4. Rabson, A. B. & Graves, B. J. in Retroviruses (eds Coffin, J. M., Hughes, S. M. & Varmus, H. E.) 205-261 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1997).
5. Swanstrom, R. & Willis, J. W. in Retroviruses (eds Coffin, J. M., Hughes, S. M. & Varmus, H. E.) 263-334 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1997).
6. Butsch, M. & Boris-Lawrie, K. Destiny of unspliced retroviral RNA: ribosome and/or virion? J. Virol. 76, 3089-3094 (2002).
7. Levin, J. G. & Rosenak, M. J. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: Evidence for persistence of viral messenger RNA. Proc. Natl Acad. Sci. USA 73, 1154-1158 (1976).
8. Griffin, S. D., Allen, J. F. & Lever, A. M. The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: Cotranslational RNA encapsidation and limitation of Gag protein confer specificity. J. Virol. 75, 12058-12069 (2001).
9. Kaye, J. F. & Lever, A. M. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72, 5877-5885 (1998).
10. Cimarelli, A. & Darlix, J. L. Assembling the human immunodeficiency virus type 1. Cell. Mol. Life Sci. 59, 1166-1184 (2002).
11. Brugger, B. et al. The HIV lipidome: A raft with an unusual composition. Proc. Natl Acad. Sci. USA 103, 2641-2646 (2006).
12. Morikawa, Y. HIV capsid assembly. Curr. HIV Res. 1, 1-14 (2003).
13. Saad, J. S. et al. From the cover: Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA 103, 11364-11369 (2006).
14. Berkhout, B. Structure and function of the human immunodeficiency virus leader RNA. Prog. Nucleic Acid Res. Mol. Biol. 54, 1-34 (1996).
15. Berkhout, B. et al. In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J. Biol. Chem. 277, 19967-19975 (2002).
16. Corbin, A. & Darlix, J. L. Functions of the 5′ leader of murine leukemia virus genomic RNA in virion structure, viral replication and pathogenesis, and MLV-derived vectors. Biochimie 78, 632-638 (1996).
17. Das, A. T., Klaver, B. & Berkhout, B. The 5′ and 3′ TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J. Virol. 72, 9217-9223 (1998).
18. Klasens, B. I., Thiesen, M., Virtanen, A. & Berkhout, B. The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res. 27, 446-454 (1999).
19. Yoshinaka, Y., Katoh, I., Copeland, T. D. & Oroszlan, S. Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proc. Natl Acad. Sci. USA 82, 1618-1622 (1985).
20. Honigman, A., Wolf, D., Yaish, S., Falk, H. & Panet, A. cis Acting RNA sequences control the gag-pol translation readthrough in murine leukemia virus. Virology 183, 313-319 (1991).
21. Jacks, T., Madhani, H. D., Masiarz, F. R. & Varmus, H. E. Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell 55, 447-458 (1988).
22. Mardon, G. & Varmus, H. E. Frameshift and intragenic suppressor mutations in a Rous sarcoma provirus suggest src encodes two proteins. Cell 32, 871-879 (1983).
23. Brierley I., Digard, P. & Inglis, S. C. Characterization of an efficient coronavirus ribosomal frameshifting signal: Requirement for an RNA pseudoknot. Cell 57, 537-547 (1989).
24. Namy O., Moran, S. J., Stuart, D. I., Gilbert, R. J. & Brierley I. A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting. Nature 441, 244-247 (2006).
25. Shehu-Xhilaga, M., Crowe, S. M. & Mak, J. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J. Virol. 75, 1834-1841 (2001).
26. Prats, A. C., De Billy, G., Wang. P. & Darlix, J. L. CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus. J. Mol. Biol. 205, 363-372 (1989).
27. Portis. J. L., Fujisawa, R. & McAtee, F. J. The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: Analysis of second site revertants of a mutant MuLV lacking expression of this protein. Virology 226, 384-392 (1996).
28. Corbin, A., Prats, A. C., Darlix, J. L. & Sitbon, M. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J. Virol. 68, 3857-3867 (1994).
29. Berlioz, C. & Darlix, J. L. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J. Virol. 69, 2214-2222 (1995).
30. Vagner, S. et al. Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor. J. Biol. Chem. 270, 20376-20383 (1995).
31. Cepko, C. L., Roberts, B. E. & Mulligan, R. C. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 37, 1053-1062 (1984).
32. Deffaud, C. & Darlix, J. L. Characterization of an internal ribosomal entry segment in the 5′ leader of murine leukemia virus env RNA. J. Virol. 74, 846-850 (2000).
33. Berlioz, C., Torrent, C. & Darlix, J. L. An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors. J. Virol. 69, 6400-6407 (1995).
34. Lopez-Lastra, M., Ulrici, S., Gabus, C. & Darlix, J. L. Identification of an internal ribosome entry segment in the 5′ region of the mouse VL30 retrotransposon and its use in the development of retroviral vectors. J. Virol. 73, 8393-8402 (1999).
35. Urisman, A. et al. Identification of a novel γ retrovirus in prostate tumors of patients homozygous for R462O RNASEL variant. PLoS Pathog 2, e25 (2006).
36. Lopez-Lastra, M., Gabus, C. & Darlix, J. L. Characterization of an internal ribosomal entry segment within the 5′ leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectors. Hum. Gene Ther. 8, 1855-1865 (1997).
37. Darlix, J. L., Zuker, M. & Spahr, P. F. Structure-function relationship of Rous sarcoma virus leader RNA. Nucleic Acids Res. 10, 5183-5196 (1982).
38. Donze, O., Damay, P. & Spahr, P. F. The first and third uORFs in RSV leader RNA are efficiently translated: Implications for translational regulation and viral RNA packaging. Nucleic Acids Res. 23, 861-868 (1995).
39. Donze, O. & Spahr, P. F. Role of the open reading frames of Rous sarcoma virus leader RNA in translation and genome packaging. EMBO J. 11, 3747-3757 (1992).
40. Deffaud, C. & Darlix, J. L. Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5′ leader of the genomic RNA. J. Virol. 74, 11581-11588 (2000).
41. Ronfort, C., De Breyne, S., Sandrin, V., Darlix, J. L. & Ohlmann, T. Characterization of two distinct RNA domains that regulate translation of the Drosophila gypsy retroelement. Rna 10, 504-515 (2004).
42. Buck, C. B. et al. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J. Virol. 75, 181-191 (2001).
43. Brasey, A. et al. The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J. Virol. 77, 3939-3949 (2003).
44. Herbreteau, C. H. et al. HIV-2 genomic RNA contains a novel type of IRES located downstream of its initiation codon. Nature Struct. Mol. Biol. 12, 1001-1007 (2005).
45. Nicholson, M. G., Rue, S. M., Clements, J. E. & Barber, S. A. An internal ribosome entry site promotes translation of a novel SIV Pr55(Gag) isoform. Virology (2006).
46. Ohlmann, T., Lopez-Lastra, M. & Darlix, J. L. An internal ribosome entry segment promotes translation of the simian immunodeficiency virus genomic RNA. J. Biol. Chem. 275, 11899-11906 (2000).
47. Miele, G., Mouland, A., Harrison, G. P., Cohen, E. & Lever, A. M. The human immunodeficiency virus type 1 5′ packaging signal structure affects translation but does not function as an internal ribosome entry site structure. J. Virol. 70, 944-951 (1996).
48. Yilmaz, A., Bolinger, C. & Boris-Lawrie, K. Retrovirus translation initiation: Issues and hypotheses derived from study of HIV-1. Curr. HIV Res 4, 131-139 (2006).
49. Abbink, T. E. & Berkhout, B. A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J. Biol. Chem. 278, 11601-11611 (2003).
50. Dirac, A. M., Huthoff, H., Kjems, J. & Berkhout, B, Regulated HIV-2 RNA dimerization by means of alternative RNA conformations. Nucleic Acids Res. 30, 2647-2655 (2002).
51. Huthoff, H. & Berkhout, B. Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic Acids Res. 29, 2594-2600 (2001).
52. Huthoff, H. & Berkhout, B. Multiple secondary structure rearrangements during HIV-1 RNA dimerization. Biochemistry 41, 10439-10445 (2002).
53. Abbink, T. E., Ooms, M., Haasnoot, P. C. & Berkhout, B. The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochemistry 44, 9058-9066 (2005).
54. Dorokhov, Y. L. et al. Polypurine (A)-rich sequences promote cross-kingdom conservation of internal ribosome entry. Proc. Natl Acad. Sci. USA 99, 5301-5306 (2002).
55. Lanchy. J. M., Ivanovitch, J. D. & Lodmell, J. S. A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA. Rna 9, 1007-1018 (2003).
56. Damgaard, C. K., Andersen, E. S., Knudsen, B., Gorodkin, J. & Kjems, J. RNA interactions in the 5′ region of the HIV-1 genome. J. Mol. Biol. 336, 369-379 (2004).
57. Paillart, J. C., Skripkin, E., Ehresmann, B., Ehresmann, C. & Marquet, R. In vitro evidence for a long range pseudoknot in the 5′-untranslated and matrix coding regions of HIV-1 genomic RNA. J. Biol. Chem. 277, 5995-6004 (2002).
58. Paillart, J. C. et al. First snapshots of the HIV-1 RNA structure in infected cells and in virions. J. Biol. Chem. 279, 48397-48403 (2004).
59. Anderson, E. C. & Lever, A. M. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J. Virol. 80, 10478-10486 (2006).
60. Hackett, P. B., Dalton, M. W., Johnson, D. P. & Petersen, R. B. Phylogenetic and physical analysis of the 5′ leader RNA sequences of avian retroviruses. Nucleic Acids Res. 19, 6929-6934 (1991).
61. Bieth, E., Gabus, C. & Darlix. J. L. A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro. Nucleic Acids Res. 18, 119-127 (1990).
62. Sonstegard, T. S. & Hackett, P. B. Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76gag. J. Virol. 70, 6642-6652 (1996).
63. Banks, J. D., Kealoha, B. O. & Linial, M. L. An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles. J. Virol. 73, 8926-8933 (1999).
64. Banks, J. D., Yeo, A., Green, K., Cepeda, F. & Linial, M. L. A minimal avian retroviral packaging sequence has a complex structure. J. Virol. 72, 6190-6194 (1998).
65. Butsch, M., Hull, S., Wang, Y., Roberts, T. M. & Boris-Lawrie, K. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production. J. Virol. 73, 4847-4855 (1999).
66. Hull, S. & Boris-Lawrie, K. RU5 of Mason-Pfizer monkey virus 5′ long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA. J. Virol. 76, 10211-10218 (2002).
67. Roberts, T. M. & Boris-Lawrie, K. The 5′ RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA. J. Virol. 74, 8111-8118 (2000).
68. Hull, S. & Boris-Lawrie, K. Analysis of synergy between divergent simple retrovirus posttranscriptional control elements. Virology 317, 146-154 (2003).
69. Hartman, T. R. et al. RNA helicase A is necessary for translation of selected messenger RNAs. Nature Struct. Mol. Biol. 13, 509-516 (2006).
70. Rosen, C. A., Sodroski, J. G. & Haseltine, W. A. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41, 813-823 (1985).
71. Muesing, M. A., Smith, D. H. & Capon, D. J. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48, 691-701 (1987).
72. Hauber, J. & Cullen, B. R. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. J. Virol. 62, 673-679 (1988).
73. Bannwarth, S. & Gatignol, A. HIV-1 TAR RNA: The target of molecular interactions between the virus and its host. Curr. HIV Res. 3, 61-71 (2005).
74. Parkin, N. T. et al. Mutational analysis of the 5′ non-coding region of human immunodeficiency virus type 1: Effects of secondary structure on translation. EMBO J. 7, 2831-2837 (1988).
75. Edery, I., Petryshyn, R. & Sonenberg, N. Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: A novel translational control mechanism. Cell 56, 303-312 (1989).
76. Maitra, R. K. et al. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204, 823-827 (1994).
77. Kaufman, R. J. in Translational Control of Gene Expression (eds Sonenberg, N., Hershey, J. W. & Mathews, M. B.) 1020 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 2000).
78. Pain, V. M. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236, 747-771 (1996).
79. Schroder, H. C., Kelve, M. & Muller, W. E. The 2-5A system and HIV infection. Prog. Mol. Subcell. Biol. 14, 176-197 (1994).
80. Silverman, R. H. & Sengupta, D. N. Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. J. Exp. Pathol. 5, 69-77 (1990).
81. Carpick, B. W. et al. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J. Biol. Chem. 272, 9510-9516 (1997).
82. Cosentino, G. P. et al. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl Acad. Sci. USA 92, 9445-9449 (1995).
83. Roy, S. et al. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247, 1216-1219 (1990).
84. McMillan, N. A. et al. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213, 413-424 (1995).
85. Cai, R., Carpick, B., Chun, R. F., Jeang, K. T. & Williams, B. R. HIV-1 TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch. Biochem. Biophys. 373, 361-367 (2000).
86. SenGupta, D. N., Berkhout, B., Gatignol, A., Zhou, A. M. & Silverman, R. H. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 87, 7492-7496 (1990).
87. Gatignol, A., Buckler-White, A., Berkhout, B. & Jeang, K. T. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251, 1597-1600 (1991).
88. Svitkin, Y. V., Pause, A. & Sonenberg, N. La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol. 68, 7001-7007 (1994).
89. Chang, Y. N., Kenan, D. J., Keene, J. D., Gatignol, A. & Jeang, K. T. Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J. Virol. 68, 7008-7020 (1994).
90. Fujii, R. et al. A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J. Biol. Chem. 276, 5445-5451 (2001).
91. Dugre-Brisson, S. et al. Interaction of Staufen 1 with the 5′ end of mRNA facilitates translation of these RNAs. Nucleic Acids Res. 33, 4797-4812 (2005).
92. Ben-Asouli, Y., Banai, Y., Hauser, H. & Kaempfer, R. Recognition of 5′-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2. Nucleic Acids Res. 28, 1011-1018 (2000).
93. Hadzopoulou-Cladaras, M. et al. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63, 1265-1274 (1989).
94. Zapp, M. L. & Green, M. R. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342, 714-716 (1989).
95. Dillon, P. J., Nelbock, P., Perkins, A. & Rosen, C. A. Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA. J. Virol. 64, 4428-4437 (1990).
96. Cochrane, A. W., Chen, C. H. & Rosen, C. A. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl Acad. Sci. USA 87, 1198-1202 (1990).
97. Mann, D. A. et al. A molecular rheostat. Co-operative rev binding to stem 1 of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. J. Mol. Biol. 241, 193-207 (1994).
98. Tiley, L. S., Malim, M. H., Tewary, H. K., Stockley. P. G. & Cullen, B. R. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc. Natl Acad. Sci. USA 89, 758-762 (1992).
99. Bartel, D. P., Zapp, M. L., Green, M. R. & Szostak, J. W. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67, 529-536 (1991).
100. Iwai, S., Pritchard, C., Mann, D. A., Karn, J. & Gait, M. J. Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type-1 rev protein. Nucleic Acids Res. 20, 6465-6472 (1992).
101. Kjems, J., Calnan, B. J., Frankel, A. D. & Sharp, P. A. Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11, 1119-1129 (1992).
102. Heaphy, S. et al. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell 60, 685-693 (1990).
103. Kimura, T., Hashimoto, I., Nishikawa, M. & Fujisawa, J. I. A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal β-actin and viral protein expression. Biochimie 78, 1075-1080 (1996).
104. Arrigo, S. J. & Chen, I. S. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5, 808-819 (1991).
105. D'Agostino, D. M., Felber, B. K., Harrison, J. E. & Pavlakis, G. N. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol. Cell Biol. 12, 1375-1386 (1992).
106. Perales, C., Carrasco, L. & Gonzalez, M. E. Regulation of HIV-1 env mRNA translation by Rev protein. Biochim. Biophys. Acta 1743, 169-175 (2005).
107. Lawrence, J. B., Cochrane, A. W., Johnson, C. V., Perkins, A. & Rosen, C. A. The HIV-1 Rev protein: A model system for coupled RNA transport and translation. New Biol. 3, 1220-1232 (1991).
108. Gulick, R. M. et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337, 734-739 (1997).
109. Hammer, S. M. et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337, 725-733 (1997).
110. Blanco, R., Carrasco, L. & Ventoso, I. Cell killing by HIV-1 protease. J. Biol. Chem. 278, 1086-1093 (2003).
111. Prevot, D., Darlix, J. L. & Ohlmann, T. Conducting the initiation of protein synthesis: The role of eIF4G. Biol. Cell. 95, 141-156 (2003).
112. Ventoso, I., Blanco, R., Perales, C. & Carrasco, L. HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc. Natl Acad. Sci. USA 23, 23 (2001).
113. Ohlmann, T. et al. In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system. J. Mol. Biol. 318, 9-20 (2002).
114. Prevot, D. et al. Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning. EMBO J. 22, 1909-1921 (2003).
115. Lamphear, B. J., Kirchweger, R., Skern, T. & Rhoads, R. E. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J. Biol. Chem. 270, 21975-21983 (1995).
116. Ziegler, E., Borman, A. M., Kirchweger, R., Skern, T. & Kean, K. M. Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and enterovirus IRES-driven translation and cleave several proteins of cellular and viral origin. J. Virol. 69, 3465-3474 (1995).
117. Ziegler, E. et al. Picornavirus 2A proteinase-mediated stimulation of internal initiation of translation is dependent on enzymatic activity and the cleavage products of cellular proteins. Virology 213, 549-557 (1995).
118. Ohlmann, T., Rau, M., Pain, V. M. & Morley, S. J. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E. EMBO J. 15, 1371-1382 (1996).
119. Alvarez, E., Menendez-Arias, L. & Carrasco, L. The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J. Virol. 77, 12392-12400 (2003).
120. Alvarez, E., Castello, A., Menendez-Arias, L. & Carrasco, L. HIV protease cleaves poly (A)-binding protein. Biochem. J. 396, 219-226 (2006).
121. Butsch, M. & Boris-Lawrie, K. Translation is not required to generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells. J. Virol. 74, 11531-11537 (2000).
122. Sarnow, P. Translational control during virus infection. Virus Res. 119, 1 (2006).
123. Schlick, P. & Skern, T. Eukaryotic initiation factor 4GI is a poor substrate for HIV-1 proteinase. FEBS Lett. 529, 337-340 (2002).
124. Gradi, A., Svitkin, Y. V., Imataka, H. & Sonenberg, N. Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc. Natl Acad. Sci. USA 95, 11089-11094 (1998).
125. Svitkin, Y. V., Gradi, A., Imataka, H., Morino, S. & Sonenberg, N. Eukaryotic initiation factor 4GII (eIF4GII), but not eIF4GI, cleavage correlates with inhibition of host cell protein synthesis after human rhinovirus infection. J. Virol. 73, 3467-3472 (1999).
126. Planelles, V. et al. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70, 2516-2524 (1996).
127. Pyronnet, S., Dostie, J. & Sonenberg, N. Suppression of cap-dependent translation in mitosis. Genes Dev. 15, 2083-2093 (2001).
128. Sarnow, P., Cevallos, R. C. & Jan, E. Takeover of host ribosomes by divergent IRES elements. Biochem. Soc. Trans. 33, 1479-1482 (2005).
129. Jackson, R. J. Alternative mechanisms of initiating translation of mammalian mRNAs. Biochem. Soc. Trans. 33, 1231-1241 (2005).
130. Lopez-Lastra, M., Rivas, A. & Barria, M. I. Protein synthesis in eukaryotes: The growing biological relevance of cap-independent translation initiation. Biol. Res. 38, 121-146 (2005).
131. Komar, A. A. & Hatzoglou, M. Internal ribosome entry sites in cellular mRNAs: Mystery of their existence. J. Biol. Chem. 280, 23425-23428 (2005).
132. Martinez-Salas, E. & Fernandez-Miragall, O. Picornavirus IRES: Structure function relationship. Curr. Pharm. Des. 10, 3757-3767 (2004).
133. Bonnal, S., Boutonnet, C., Prado-Lourenco, L. & Vagner, S. IRESdb: The internal ribosome entry site database. Nucleic Acids Res. 31, 427-428 (2003).
134. Mokrejs, M. et al. IRESite: The database of experimentally verified IRES structures Nucleic Acids Res. 34, D125-D130 (2006).
135. Pisarev, A. V., Shirokikh, N. E. & Hellen, C. U. Translation initiation by factor-independent binding of eukaryotic ribosomes to internal ribosomal entry sites. C. R. Biol 328, 589-605 (2005).
136. Richter, J. D. & Sonenberg, N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433, 477-480 (2005).
137. Stein, I. et al. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia. Mol. Cell. Biol. 18, 3112-3119 (1998).
138. Lang, K. J., Kappel, A. & Goodall, G. J. Hypoxia-inducible factor-1α mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol. Biol. Cell 13, 1792-1801 (2002).
139. Holcik, M., Sonenberg, N. & Korneluk, R. G. Internal ribosome initiation of translation and the control of cell death. Trends Genet. 16, 469-473 (2000).
140. Stoneley, M. et al. c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol. Cell. Biol. 20, 1162-1169 (2000).
141. Akiri, G. et al. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene 17, 227-236 (1998).
142. Fernandez, J. et al. Internal ribosome entry site-mediated translation of a mammalian mRNA is regulated by amino acid availability. J. Biol. Chem. 276, 12285-12291 (2001).
143. Kim, Y. K. & Jang, S. K. Continuous heat shock enhances translational initiation directed by internal ribosomal entry site. Biochem. Biophys. Res. Commun. 297, 224-231 (2002).
144. Gingras, A. C., Raught, B. & Sonenberg, N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68, 913-963 (1999).
145. Pestova, T. V. et al. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl Acad. Sci. USA 98, 7029-7036 (2001).
146. Tarun, S. Z. Jr & Sachs, A. B. Association of the yeast poly (A) tail binding protein with translation initiation factor eIF-4G. EMBO J. 15, 7168-7177 (1996).
147. Imataka, H., Gradi, A. & Sonenberg, N. A newly identified N-terminal amino acid sequence of human eIF4G binds poly (A)-binding protein and functions in poly (A)-dependent translation. EMBO J. 17, 7480-7489 (1998).
148. Kozak, M. The scanning model for translation: An update. J. Cell Biol. 108, 229-241 (1989).